CHRM5 and myeloid sarcoma: Although this suggests an important role of CHRM5 in human CNS MS pathology, ultimately, more functional loss-of-function studies are needed to link the downregulation of CHRM5 to the upregulation of myelin transcripts to provide a mechanistic link.